PREVIEW: CVS Health Corp (CVS) earnings due 09/Feb at 11:40GMT/06:40EST

CVS Health Corp (CVS) Q4 2021 (USD): EPS (exp. 1.93/0.93 GAAP), Revenue (exp. 75.67bln)

REVENUE SEGMENTS:

• Health Care Benefits: (exp. 20.64bln)
• Pharmacy Services Segment: (exp. 39.17bln)
• Retail/ Long Term Care: (exp. 26.42bln)

DIVIDEND:

• Qtrly Dividend: (exp. 0.50)
• FY Dividend: (exp. 2.00)

EPS GUIDANCE:

• Q1 2022 EPS View: (exp. 2.12/1.76 GAAP)
• FY 2022 EPS View: (exp. 8.28/6.94 GAAP)

REVENUE GUIDANCE:

• Q1 2022 Revenue View: (exp. 74.32bln)
• FY 2022 Revenue View: (exp. 307.62bln)

INDEX WEIGHT:

• 0.4% SPX weight
• Sector/Industry: Health Care/Health Care Providers & Services

BROKER RATING:

• Avg Rating: 'Buy'
• Avg Price Target: USD 113.41
• Price Target Changes (last 30 days): 17 upward vs 0 downward